Net Cash Provided by (Used in) Financing Activities in USD of ADMA BIOLOGICS, INC. from Q1 2011 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Adma Biologics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2025.
  • Adma Biologics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$7.13M, a 393% decline year-over-year.
  • Adma Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$58.3M, a 49.5% decline from 2023.
  • Adma Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$39M, a 136% decline from 2022.
  • Adma Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $109M, a 10.1% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

ADMA BIOLOGICS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$7.13M -$5.68M -393% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 -$1.45M -$797K -123% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 -$650K -$47.9M -101% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $47.3M +$5.43M +13% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $41.8M -$59.4M -58.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $101M +$97M +2323% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $4.18M +$4.18M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 -$4.38K* +$1.11M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 -$1.12M -$1.11M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2016 -$3.66K* -$10.5M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q1 2015 $10.5M +$5.67M +118% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q1 2014 $4.79M +$3.86M +417% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q1 2013 $926K -$15.2M -94.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $16.2M +$15.9M +5326% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 $2.58K* Jul 1, 2011 Sep 30, 2011 10-Q 2011-10-28
Q1 2011 $298K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15

ADMA BIOLOGICS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$58.3M -$19.3M -49.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 -$39M -$148M -136% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 $109M -$12.2M -10.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-18
2021 $121M -$22.8M -15.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $144M +$63.9M +79.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $80M +$37.1M +86.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $42.9M -$17.8M -29.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $60.8M +$43.9M +261% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $16.8M +$6.44M +61.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 $10.4M +$607K +6.19% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-24
2014 $9.8M -$17.8M -64.6% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
2013 $27.6M +$8.16M +41.9% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-09
2012 $19.5M +$18.2M +1409% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-28
2011 $1.29M Jan 1, 2011 Dec 31, 2011 10-K 2013-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.